Ordinary and Activated Bone Grafts: Applied Classification and the Main Features

Bone defects remain a significant clinical challenge, especially in atrophic regions. Current treatment strategies rely heavily on bone grafts. Prior research has shown that bone grafts vary in composition and biological activity. However, no prior work had resolved a clear, standardized classification system for these materials. This gap motivated the development of a new framework. The distinction between passive and active graft types is not well defined in existing literature. That uncertainty drove the need for a classification based on biological properties. No prior work had resolved the role of standardized active components in graft performance.

This study aimed to propose a classification system for bone grafts based on biological activity. The authors sought to differentiate between ordinary and activated grafts. The motivation came from the need for a standardized framework. Current classifications lack clarity on the role of active components. The goal was to establish a clear, evidence-based distinction. The authors focused on the presence of standardized growth factors or cells. This distinction helps guide clinical decisions. The purpose was to improve the understanding of graft efficacy in bone regeneration.

The researchers reviewed modern groups of bone grafts and their compositions. They analyzed the biological mechanisms and therapeutic applications. The classification was based on the presence of active components. Growth factors, cells, and gene constructs were considered key indicators. Qualitative and quantitative parameters were used for standardization. The team evaluated osteoinductive and osteogenic properties. No prior work had resolved the exact criteria for activation. The approach combined literature review with clinical relevance.

The proposed classification separates bone grafts into ordinary and activated categories. Activated grafts contain standardized biologically active components. Ordinary grafts lack such standardized active elements. The main feature of activated grafts is their osteoinductive and osteogenic properties. These properties are essential for large bone defect substitution. The study found that activated materials show higher efficacy in such cases. No prior work had resolved the exact mechanisms of activation. The results suggest a need for standardized definitions in clinical practice.

The authors propose that the presence of standardized active components defines activated grafts. This classification helps clarify the biological role of different graft types. The study supports the use of activated grafts for large bone defects. The findings suggest that ordinary grafts may be less effective in such cases. The authors emphasize the importance of standardization in graft composition. No prior work had resolved the exact criteria for activation. The conclusions align with the observed biological properties of the materials. The framework provides a basis for future clinical decision-making.